180 related articles for article (PubMed ID: 6100599)
1. Enalapril (MK421) in the treatment of hypertension with renal artery stenosis.
Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
J Hypertens Suppl; 1983 Oct; 1(1):109-17. PubMed ID: 6100599
[TBL] [Abstract][Full Text] [Related]
2. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function.
Tillman DM; Malatino LS; Cumming AM; Hodsman GP; Leckie BJ; Lever AF; Morton JJ; Webb DJ; Robertson JI
J Hypertens Suppl; 1984 Dec; 2(2):S93-100. PubMed ID: 6100883
[TBL] [Abstract][Full Text] [Related]
3. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
[TBL] [Abstract][Full Text] [Related]
4. Enalapril in the treatment of hypertension with renal artery stenosis.
Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson I; Robertson JI
Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1413-7. PubMed ID: 6315126
[TBL] [Abstract][Full Text] [Related]
5. Physiological effects of short-term treatment with enalapril in hypertensive patients.
de Leeuw PW; Hoogma RP; van Soest GA; van Es PN; Birkenhäger WH
J Hypertens Suppl; 1983 Oct; 1(1):87-91. PubMed ID: 6100612
[TBL] [Abstract][Full Text] [Related]
6. Effect of enalapril on renin, angiotensin converting enzyme activity, aldosterone and prostaglandins in patients with hypertension.
Larochelle P; Gutkowska J; Schiffrin E; Kuchel O; Hamet P; Genest J
Clin Invest Med; 1985; 8(3):197-201. PubMed ID: 2994932
[TBL] [Abstract][Full Text] [Related]
7. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.
Jackson B; Franze L; Sumithran E; Johnston CI
J Lab Clin Med; 1990 Jan; 115(1):21-7. PubMed ID: 2299253
[TBL] [Abstract][Full Text] [Related]
9. Clonidine in unilateral renal artery stenosis and unilateral renal parenchymal disease--similar antihypertensive but different renin suppressive effects.
Mathias CJ; Wilkinson AH; Pike FA; Sever PS; Peart WS
J Hypertens Suppl; 1983 Dec; 1(2):123-5. PubMed ID: 6400111
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
11. Transrenal changes in active and inactive renin and angiotensin II in renal artery stenosis: effects of converting enzyme inhibition.
Tillman DM; Malatino LS; Lever AF; Robertson JI
Kidney Int Suppl; 1987 May; 20():S184-90. PubMed ID: 3037169
[No Abstract] [Full Text] [Related]
12. Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.
Hodsman GP; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Murray GD; Robertson JI
Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1697-9. PubMed ID: 6293638
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical experience with enalapril in essential hypertension.
Brunner HR; Waeber B; Nussberger J; Schaller MD; Gomez HJ
J Hypertens Suppl; 1983 Oct; 1(1):103-7. PubMed ID: 6100598
[TBL] [Abstract][Full Text] [Related]
14. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C
Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
[TBL] [Abstract][Full Text] [Related]
15. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
[TBL] [Abstract][Full Text] [Related]
16. The clinical pharmacology of enalapril.
Gomez HJ; Cirillo VJ; Jones KH
J Hypertens Suppl; 1983 Oct; 1(1):65-70. PubMed ID: 6100610
[TBL] [Abstract][Full Text] [Related]
17. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J
Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161
[TBL] [Abstract][Full Text] [Related]
18. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
19. Occlusion of unilateral stenosed renal arteries--relation to medical treatment.
Postma CT; Hoefnagels WH; Barentsz JO; de Boo T; Thien T
J Hum Hypertens; 1989 Jun; 3(3):185-90. PubMed ID: 2769675
[TBL] [Abstract][Full Text] [Related]
20. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
